Prophylactic platelet transfusion in acute leukemia: which threshold should be used
Finazzi, G.
Haematologica 83(11): 961-962
1998
ISSN/ISBN: 0390-6078 PMID: 9864912 Document Number: 486802
Document emailed within 1 workday
Related Documents
Murphy, W.G. 1992: Prophylactic platelet transfusion in acute leukaemia Lancet 339(8785): 120; Author Reply 120-1Almasio, P.; Mirto, S.; Malleo, C.; Di Marco, V.; Caronia, F.; Craxi, A. 1991: Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia Haematologica 76(5): 429-430
Vassallo, R.R. 2009: Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients Immunohematology 25(3): 119-124
Amemiya, Y. 1997: Platelet transfusion refractoriness and effective management of platelet alloimmunization Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2392-2398
Holme, S.; Murphy, S. 1983: Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion Journal of Laboratory and Clinical Medicine 101(1): 161-174
Cabral, E.; Gomes Filho, J.M.; Gansl, R.C.; Silveira, P.A.; Menosi, S.F.; Zanichelli, M.A.; Tobos, K.; Pozzi, D. 1979: Acute lymphoblastic leukemia. Preliminary study of 2 therapeutic regimens, one without prophylactic radiotherapy of central nervous system involvement Revista do Hospital das Clinicas 34(5): 222-226
Liu, H.C.; Liang, D.C.; Chen, S.H.; Lo, C.Y.; Tseng, K.P.; Kuo, T.B.; Chen, H.J.; Wang, S.J. 1996: Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 37(2): 107-110
Drinnan, C.R.; Miller, J.D.; Guyda, H.J.; Esseltine, D.W.; Chevalier, L.M.; Freeman, C.R. 1985: Growth and development of long-term survivors of childhood acute lymphoblastic leukemia treated with and without prophylactic radiation of the central nervous system Clinical and Investigative Medicine. Medecine Clinique et Experimentale 8(4): 307-314
Green, D.; Tiro, A.; Basiliere, J.; Mittal, K.K. 1976: Cytotoxic antibody complicating platelet support in acute leukemia. Response to chemotherapy JAMA 236(9): 1044-1046
Guzeloz, Z.; Demiral, A.N.; Eren, F.; Adigul, M.; Capar, A.E.; Cakmakci, H.; Yilmaz, S.; Tufekci, O.; Oren, H.; Çetingoz, R. 2017: The Effect of Dose-Volume Parameters on Central Nervous System Relapse in Pediatric Patients with Acute Leukemia Receiving Prophylactic Cranial Irradiation Gulf Journal of Oncology 1(24): 24-29
Valeri, C.Robert.; Ragno, G.M. 2010: Prophylactic platelet transfusions New England Journal of Medicine 362(22): 2141; Author Reply 2141-2142
Pintado, T.; Maldonado, J.E. 1976: Ultrastructure of platelet aggregation in refractory anemia and myelomonocytic leukemia. II. Individual platelet abnormalities: thrombasthenia-like platelets, surface defects, and dissociation phenomena Mayo Clinic Proceedings 51(7): 443-451
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Castaigne, S. 1981: Platelet transfusion La Revue du Praticien 31(7): 519-522
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Verstraete, M. 1979: Prophylactic value of platelet anti-aggregants in coronary disease La Clinica Terapeutica 91(2): 117-127
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
McFarland, J.G. 1996: Alloimmunization and platelet transfusion Seminars in Hematology 33(4): 315-328
Juji, T. 1978: Platelet and granulocyte transfusion and HLA Rinsho Byori. Japanese Journal of Clinical Pathology 26(10): 856-860